MYRIAD GENETICS
DEAD

Serial Number

90660104

Owner

Myriad Genetics, Inc.

Attorney

Katherine P. Califa

Filing Date

Apr 21, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MYRIAD GENETICS Trademark

Serial Number: 90660104

MYRIAD GENETICS is a trademark filed by Myriad Genetics, Inc. on April 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

Myriad Genetics, Inc. (108 trademarks)

320 Wakara Way
Salt Lake City, UT 84108

Entity Type: 03

Trademark Details

Filing Date

April 21, 2021

Registration Date

Not Registered

Published for Opposition

November 30, 2021

Goods & Services

Medical test kits comprising chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; medical diagnostic reagents, assays, chemical preparations, and diagnostic test kits consisting primarily of reagents for medical diagnostic purposes, namely, testing of fluids; chemical reagents for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic test kits comprised of chemical reagents and chemical preparations for medical use in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; diagnostic kits consisting primarily of reagents for body fluid analysis and nucleic acid analysis and for detecting genetic conditions, disorders, and diseases for medical use

Medical test kits comprising specimen collection tubes and containers for collecting patient specimens, printed test forms, printed mailing materials, and printed user information inserts used in connection with the detection of gene mutations, gene expression profiles, and other molecular abnormalities, indicators, and markers for use in prognosing or predicting progression and severity of disease and predisposition to developing disease and for use in evaluating and selecting therapy or treatment regimens; sample preparation device for medical diagnostic uses; medical apparatus and instruments for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of tissue-based diagnostic testing, cytology and cell-based testing; blood, urine, and saliva medical specimen collection kits consisting of test tubes and self-mailer, used for health and genetic analysis and diagnostics

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Aug 28, 2023 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Aug 28, 2023 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 20, 2022 EXRA
SOU EXTENSION 2 GRANTED
Dec 16, 2022 EX2G
SOU EXTENSION 2 FILED
Dec 16, 2022 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 16, 2022 EEXT
CORRECTED NOA E-MAILED
Oct 13, 2022 NOAC
DIVISIONAL PROCESSING COMPLETE
Oct 12, 2022 DPCC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 11, 2022 AITU
DIVISIONAL REQUEST RECEIVED
Sep 22, 2022 DRRR
TEAS REQUEST TO DIVIDE RECEIVED
Sep 22, 2022 ERTD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 27, 2022 EXRA
SOU EXTENSION 1 GRANTED
Jul 25, 2022 EX1G
SOU EXTENSION 1 FILED
Jul 25, 2022 EXT1
SOU TEAS EXTENSION RECEIVED
Jul 25, 2022 EEXT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 17, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 17, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 17, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 17, 2022 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 17, 2022 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 27, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 27, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 27, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 27, 2022 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jan 25, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 30, 2021 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 25, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 25, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 25, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 25, 2021 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRN
NON-FINAL ACTION E-MAILED
Sep 8, 2021 GNRT
NON-FINAL ACTION WRITTEN
Sep 8, 2021 CNRT
ASSIGNED TO EXAMINER
Sep 6, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 28, 2021 NWOS
NEW APPLICATION ENTERED
Apr 24, 2021 NWAP